Rachel E. Beard
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
-
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
Papers in
-
- Hepatocellular Carcinoma Treatment and Prognosis 7
- Liver Diseases and Immunity 1
- Oncology 9
- Pancreatic and Hepatic Oncology Research 5
- CAR-T cell therapy research 2
- Co-authors
- Allan Tsung (5 shared papers)Zhili Zheng (3 shared papers)Shannon F. Rosati (3 shared papers)Steven A. Rosenberg (3 shared papers)Daniel Abate‐Daga (3 shared papers)Sidrah Khan (3 shared papers)Kevin P. Charpentier (4 shared papers)Richard A. Morgan (1 shared paper)
- Journals
- Surgery (1 paper)Annals of Surgical Oncology (1 paper)Journal of the American College of Surgeons (1 paper)Surgical Clinics of North America (1 paper)Journal for ImmunoTherapy of Cancer (1 paper)
- Partner nations
- United StatesBelgiumIndia
In The Last Decade
Rachel E. Beard
20 papers receiving 494 citations
Peers
Comparison fields: 5 of 41
- Hepatology 151
- Oncology 174
- Pulmonary and Respiratory Medicine 74
- Surgery 91
- Immunology 37
Countries citing papers authored by Rachel E. Beard
This map shows the geographic impact of Rachel E. Beard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel E. Beard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel E. Beard more than expected).
Fields of papers citing papers by Rachel E. Beard
This network shows the impact of papers produced by Rachel E. Beard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel E. Beard. The network helps show where Rachel E. Beard may publish in the future.
Co-authors
The 25 scholars most cited alongside Rachel E. Beard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 137 | |
| 2 | 2018 | 65 | |
| 3 | 2019 | 61 | |
| 4 | 2013 | 53 | |
| 5 | 2019 | 35 | |
| 6 | 2014 | 26 | |
| 7 | 2018 | 26 | |
| 8 | 2013 | 25 | |
| 9 | 2017 | 19 | |
| 10 | 2018 | 15 | |
| 11 | 2017 | 11 | |
| 12 | 2014 | 9 | |
| 13 | 2020 | 5 | |
| 14 | 2022 | 5 | |
| 15 | 2021 | 4 | |
| 16 | 2022 | 4 | |
| 17 | 2023 | 4 | |
| 18 | 2017 | 1 | |
| 19 | 2019 | 1 | |
| 20 | 2020 | 1 |
About Rachel E. Beard
Rachel E. Beard is a scholar working on Hepatology, Oncology, Pulmonary and Respiratory Medicine, Immunology and Public Health, Environmental and Occupational Health, having authored 21 papers that have together received 507 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Pancreatic and Hepatic Oncology Research (5 papers), Gallbladder and Bile Duct Disorders (4 papers), CAR-T cell therapy research (2 papers), Immunotherapy and Immune Responses (2 papers), Palliative Care and End-of-Life Issues (2 papers), Liver Diseases and Immunity (1 paper) and Cholangiocarcinoma and Gallbladder Cancer Studies (1 paper). The work is most often cited by research in Hepatology (151 citations), Oncology (174 citations), Pulmonary and Respiratory Medicine (74 citations), Surgery (91 citations) and Immunology (37 citations). Rachel E. Beard has collaborated with scholars based in United States, Belgium and India. Frequent co-authors include Allan Tsung, Zhili Zheng, Shannon F. Rosati, Steven A. Rosenberg, Daniel Abate‐Daga, Sidrah Khan, Kevin P. Charpentier, Richard A. Morgan, Howard Alan Fine and Kiran H. Lagisetty. Their work appears in journals such as Surgery, Annals of Surgical Oncology, Journal of the American College of Surgeons, Surgical Clinics of North America and Journal for ImmunoTherapy of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.